Vermeulens
In the News
University of Tennessee’s Agriculture & Natural Resources Building (ANRB) Creates Living Research Environment
The $93 million Agriculture & Natural Resources Building (ANRB) at the University of Tennessee, Knoxville provides enhanced research, education, and collaboration with advanced technology, specialized labs, flexible classrooms, a large commons area, a 500-seat auditorium, lecture halls, seamless connections to nearby academic buildings, and a welcoming pedestrian plaza to engage the community. A biophilic design connects students, faculty, and staff with nature through the use of clerestory windows and a green roof that acts as an exterior living room with research gardens.
Texas A&M-Texarkana to Break Ground on Business, Engineering, and Technology Building
Texas A&M-Texarkana is planning to break ground in late May of 2024 on the Business, Engineering, and Technology Building (BET), a 53,500-sf facility housing those three interdisciplinary programs. The $45 million project also includes a renovation of the Science and Technology Building, which will connect to the new facility with walkways on the second and third floors.
Centre for Addiction and Mental Health Begins Construction on Research Facility
The Centre for Addiction and Mental Health (CAMH) began construction in January of 2024 on the Research & Discovery Centre in Toronto. Designed by TreanorHL and KPMB Architects, the 389,341-sf facility will catalyze the translation of medical breakthroughs into new solutions for patient care. This centralized home for CAMH’s research enterprise will feature open lab and office environments, space for clinical trials, and communal settings illuminated by natural light.
University of Virginia Breaks Ground on Manning Institute for Biotechnology
The University of Virginia broke ground on the $350 million Paul and Diane Manning Institute for Biotechnology in December of 2023. Located in the Fontaine Research Park in Charlottesville, the 350,000-sf project will drive innovation in the fields of cellular therapy, gene therapy, nanotechnology, and drug delivery. By collocating state-of-the-art labs and core facilities with advanced manufacturing suites and clinical environments, the four-story building will accelerate the translation of medical discoveries into new solutions for patient care.
Vermeulens Releases Q3-2022 Market Outlook
Vermeulens has released its market outlook report for the third quarter of 2022. Key points include: